Tag: biologic drugs

Explore why vaccine generics don't exist like drug generics, how this impacts global access, and the challenges of expanding international production capacity.

Switching from an originator biologic to a biosimilar is safe for most patients, backed by extensive clinical data. Learn what really happens during the switch, why some people stop, and how to make the transition smoother.